<DOC>
	<DOC>NCT01432002</DOC>
	<brief_summary>The purpose of the study is: - to assess the potential benefits of 18F-[FDG] PET/CT and PET/MRI for operable breast cancer in order to define the size and location of the primary tumor, as well as axillary, supraclavicular and internal mammary lymph nodes. - to apply the imaging results to the simulation and the radiation treatment planning and partial breast for 3-D radiation treatment and partial breast irradiation with intensity modulated radiation treatment (IMRT).</brief_summary>
	<brief_title>FDG-PET/CT for Simulation and Radiation Treatment Planning of Early Breast Cancer</brief_title>
	<detailed_description>Pre-operative FDG PET/CT, and in option PET/IRM, are intended for women with histologically confirmed operable clinically node-negative breast cancer, in whom breast conserving and post-operative radiotherapy are planned.</detailed_description>
	<mesh_term>Breast Neoplasms</mesh_term>
	<criteria>Histologically confirmed breast carcinoma Clinical stage T12 N0 M0 Age &gt; 18 years Signed informed consent WHO performance index 3 Premenopausal women without contraception Gestation Lactating Prior surgery or radiotherapy on the same breast Unable to understand study participation Bilateral breast cancer Prior CT thoraxabdomen and breast MRI within 4 months of interview Presence of electromechanical implant and/or body ferromagnetic material Previous history of renal insufficiency requiring dialysis and/or hospitalisation Ureum and/or creatinine within 2 weeks of interview above lab's reference limits History of contrast allergy Hyperthyroidy Claustrophobia.</criteria>
	<gender>Female</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>September 2014</verification_date>
	<keyword>breast carcinoma</keyword>
	<keyword>FDG</keyword>
	<keyword>PET/CT</keyword>
	<keyword>PET/IRM</keyword>
</DOC>